https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-08-27 / 2016 Feb;5(2):e1078057
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-08-27 / 2016 Feb;5(2):e10780572015-08-27 00:00:002015-08-27 00:00:00Oncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-08-27 / Biomed Res Int 2015;2015:842923
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-08-27 / Biomed Res Int 2015;2015:8429232015-08-27 00:00:002021-11-15 13:26:51Tumour Relapse Prediction Using Multiparametric MR Data Recorded during Follow-Up of GBM Patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-08-27 / J. Neurooncol. 2015 Oct;125(1):65-74
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-08-27 / J. Neurooncol. 2015 Oct;125(1):65-742015-08-27 00:00:002019-02-15 08:47:20Ex vivo generation of dendritic cells from cryopreserved, post-induction chemotherapy, mobilized leukapheresis from pediatric patients with medulloblastoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-08-26 / Appl. Biochem. Biotechnol. 2015 Oct;177(4):940-56
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-08-26 / Appl. Biochem. Biotechnol. 2015 Oct;177(4):940-562015-08-26 00:00:002019-02-15 09:22:45HN Protein of Newcastle Disease Virus Induces Apoptosis Through SAPK/JNK Pathway
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-08-24 / Technol. Cancer Res. Treat. 2016 10;15(5):NP83-94
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-08-24 / Technol. Cancer Res. Treat. 2016 10;15(5):NP83-942015-08-24 00:00:002019-02-15 09:13:32Recombinant Newcastle Disease Virus Encoding IL-12 and/or IL-2 as Potential Candidate for Hepatoma Carcinoma Therapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-08-13 / Clin Transl Oncol 2016 Jan;18(1):82-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-08-13 / Clin Transl Oncol 2016 Jan;18(1):82-72015-08-13 00:00:002015-08-13 00:00:00Prospective study of cyclophosphamide, thiotepa, carboplatin combined with adoptive DC-CIK followed by metronomic cyclophosphamide therapy as salvage treatment for triple negative metastatic breast cancers patients (aged <45)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
IOZK
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
IOZK2015-08-12 16:59:282019-02-12 17:01:22Neue Antikörper für die immunologische Krebstherapie zugelassen
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-08-08 / Crit. Rev. Oncol. Hematol. 2016 Jan;97:56-64
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-08-08 / Crit. Rev. Oncol. Hematol. 2016 Jan;97:56-642015-08-08 00:00:002015-08-08 00:00:00Therapeutic hyperthermia: The old, the new, and the upcoming
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-08-07 / J. Neurosurg. 2015 Oct;123(4):989-97
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-08-07 / J. Neurosurg. 2015 Oct;123(4):989-972015-08-07 00:00:002019-02-15 08:47:20Dendritic cell-based immunotherapy targeting Wilms‘ tumor 1 in patients with recurrent malignant glioma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-08-01 / Transl Oncol 2015 Aug;8(4):327-38
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-08-01 / Transl Oncol 2015 Aug;8(4):327-382015-08-01 00:00:002019-02-15 08:46:10Enhancement of the Immunostimulatory Functions of Ex Vivo-Generated Dendritic Cells from Early-Stage Colon Cancer Patients by Consecutive Exposure to Low Doses of Sequential-Kinetic-Activated IL-4 and IL-12. A Preliminary Study
